Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Philippine health ministry says no conditions set to access U.S. vaccines

Published 09/11/2020, 02:48 PM
Updated 09/11/2020, 02:50 PM

MANILA, Sept 11 (Reuters) - The Philippines will have access
to potential COVID-19 vaccines being developed by U.S. firms
without any strings attached, the health ministry said on
Friday, after the presidential spokesman had linked the
pardoning of a U.S. Marine to ensuring access.
Health Undersecretary Maria Rosario Vergeire said none of
the U.S. vaccine makers the government is in talks with had set
conditions, adding all potential vaccines will undergo a
regulatory process to ensure safety and efficacy.
"No conditions were provided or given to us," Vergeire told
a news conference.
The Philippines, which is among a number of developing
countries with big populations trying to secure a supply of
COVID-19 vaccine, has met with U.S. vaccine manufacturers
Moderna Inc MRNA.O and Pfizer Inc PFE.N .
It has also held discussions with China and Russia, which
are among countries leading the global race to develop
coronavirus inoculations.
Presidential Spokesman Harry Roque said on Thursday that
President Rodrigo Duterte's decision to pardon a U.S. marine
convicted of killing a transgender woman nearly six years ago
may have stemmed from his desire to ensure access to coronavirus
vaccines. But Roque reiterated on Friday that he was merely
stating a personal opinion. Pemberton was serving a six- to 10-year sentence for killing
Jennifer Laude near a former U.S. navy base in 2014. He will
likely be released from a military jail and deported this
weekend, the Bureau of Immigration said.
Philippine Ambassador to Washington Jose Manuel Romualdez
said U.S. officials were "surprised" by the pardon. While they
inquired about Pemberton, they did not push for his release, he
told ANC News channel.
The Philippines has the most COVID-19 cases in Southeast
Asia, with more than 248,000 confirmed infections.
The Southeast Asian country plans to buy 40 million doses
worth $400 million for 20 million people, about a fifth of its
107 million population.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.